Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Learn the key differences between US and EU cosmetic regulations and how to export your products from the USA to Europe in full compliance.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
The Biocidal Products Regulations (BPR) EU No. 528/2012, effective from September 2013, replaced the French Directive No. 98/8 EC. It introduces new provisions like data sharing and Union authorization, aiming to enhance human and environmental protection and simplify marketing authorization.
This guide offers technical advice on BPR obligations for active microorganisms and biocidal products, covering identification, effectiveness, and impact on humans, animals, and the environment. It replaces previous guidance documents, aligning with Annex II and III of the BPR.
Learn about the key changes in WHMIS 2015, aligned with GHS, including hazard classification, SDS requirements, labeling, and enforcement. Stay compliant with the key dates provided.
"Certibiocide" is a personal certificate for individuals handling biocides, requiring a 3-day training. It applies to specific biocide types and is valid for 5 years. Companies must comply with certain obligations, though no direct sanctions are specified for non-compliance.
This blog provides an overview of the regulatory processes and costs associated with obtaining marketing authorisation for biocidal products in the EU, including national, mutual recognition, and EU-wide authorisations. It also details the specific fees set by the French government for various authorisation evaluations.
In 2014, ECHA proposed 15 SVHCs for public consultation, approved by Member States in 2015. Substances not on the Authorisation list will be reconsidered later. These SVHCs pose health and environmental risks, with final inclusion in Annex XIV to be decided by the European Commission.
